Cortisone Shots Market Share

Rising prevalence of chronic diseases such as rheumatoid arthritis, tendinitis, and bursitis, increasing number of injuries to the joints, muscles and tendon, and the presence of key players in the market are important driver that accelerate the growth of the market. Rising geriatric population is another key driver for the market growth due to increasing prevalence of arthritis among the elderly. However, cortisone shots exhibit a number of disadvantages such as damage to the tendons, ligaments, and articular cartilage, thus restricting the growth of the market.

World Health Organization, Centers for Disease Control and Prevention (CDC), European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Research Methodology 

Segments      

The global cortisone shots market is segmented on the basis of type, indication, and end user.

On the basis of type, market is segmented into articular or joint injections, epidural steroid injection, trigger point injection, and others.

On the basis of indication, the market is segmented into rheumatoid arthritis, psoriatic arthritis, bursitis, allergic reaction, skin conditions, and others.

On the basis of end user, the market is segmented into hospitals, clinics, sport medicine centers, pharmaceutical companies, and others.

Regional Analysis of the Global Cortisone Shots Market  

America acquires the first position in the market for cortisone shots owing to the rising prevalence of various types of allergies, arthritis, tendinitis, and others, and rising demand for corticosteroid injection in the U.S. According to the Center for Disease Control and Prevention, an estimated 78 million i.e. 26% of the U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Additionally, the prevalence of tendinitis among athletes is found to be increasing from last few years in the U.S.

Europe is the second largest market for cortisone shots owing to the rising prevalence of rheumatoid arthritis in European countries, and availability of funds for research and development activities. Also, rising prevalence of allergic conditions such as asthma, food allergy, and anaphylaxis, increasing demand for diagnostic services and rising awareness about the use of cortisone injections for the treatment of tendinitis fuels the market growth.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising prevalence of diabetes, obesity, which act as risk factors for rheumatoid and osteoarthritis which is further posed to propel the growth of the market. Furthermore, rising awareness about sport injuries and the use of cortisone shots for their treatment, influences the growth of the market positively.

The Middle East & Africa also show a steady rise in the market owing to high prevalence of chronic diseases such as obesity and diabetes, and improving healthcare infrastructure. Increasing demand for new treatment options for sport injuries also influences the market growth in the Middle East & African countries.

Key Players in the Global Cortisone Shots Market    

Some of the key players in this market are Merck & Co., Inc. (U.S.), Pfizer (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG (Germany), GlaxoSmithKline (U.S.), Pharmascience Inc. (U.S.), Farmabios SPA (Italy), AdvaCare Pharma (U.S.), and others.

Intended Audience

The aging population is a significant driver of the Global Cortisone Shots Market Industry. As individuals age, they are more likely to develop chronic conditions that require management through cortisone injections. The demographic shift towards an older population is evident in many countries, leading to an increased demand for effective pain relief solutions. This trend is particularly pronounced in developed nations, where healthcare systems are adapting to cater to the needs of older adults. Consequently, the market is poised for growth, with projections indicating a substantial increase in demand for cortisone shots in the coming years.

The Global Cortisone Shots Market Industry is projected to experience substantial growth over the next decade. With a market value anticipated to reach 5.85 USD Billion by 2035, the industry is on a trajectory of expansion. This growth is underpinned by various factors, including the rising prevalence of chronic diseases, advancements in medical technology, and increasing patient awareness. The compound annual growth rate of 6.42% from 2025 to 2035 indicates a robust market environment, suggesting that cortisone shots will continue to play a vital role in pain management and treatment strategies globally.

There is a notable increase in awareness and acceptance of cortisone shots among patients and healthcare professionals, which is positively impacting the Global Cortisone Shots Market Industry. Educational initiatives and patient advocacy groups are playing a crucial role in informing individuals about the benefits and risks associated with cortisone injections. This growing understanding is leading to more patients seeking these treatments for pain management. As acceptance rises, the market is expected to grow, with estimates suggesting a market value of 5.85 USD Billion by 2035, indicating a robust future for cortisone shot therapies.

Regulatory support and updated clinical guidelines are fostering growth in the Global Cortisone Shots Market Industry. Health authorities are increasingly recognizing the therapeutic benefits of cortisone injections, leading to the establishment of clear guidelines for their use. This regulatory backing not only enhances the credibility of cortisone shots as a treatment option but also encourages healthcare providers to incorporate them into their practice. As a result, the market is likely to benefit from increased utilization and acceptance, further solidifying its position in the healthcare landscape.

Technological advancements in the administration of cortisone shots are significantly influencing the Global Cortisone Shots Market Industry. Innovations such as ultrasound-guided injections enhance precision and reduce complications, leading to improved patient outcomes. These advancements not only increase the efficacy of cortisone shots but also encourage healthcare providers to adopt these methods more widely. As a result, the market is likely to see a surge in demand, with a projected compound annual growth rate of 6.42% from 2025 to 2035. This growth reflects the ongoing evolution of treatment methodologies in the healthcare sector.

The Global Cortisone Shots Market Industry is experiencing growth due to the increasing prevalence of chronic conditions such as arthritis, asthma, and autoimmune disorders. As these conditions become more common, the demand for effective treatment options rises. Cortisone shots, known for their anti-inflammatory properties, are often utilized to manage pain and inflammation associated with these ailments. For instance, arthritis affects millions globally, leading to a heightened need for cortisone injections. This trend is expected to contribute to the market's expansion, with projections indicating a market value of 2.95 USD Billion in 2024.